Ephedrex Syrup is a multi-symptom relief formulation containing Phenylephrine (5mg/5ml), Chlorpheniramine Maleate (2mg/5ml), and Dextromethorphan Hydrobromide (10mg/5ml). Phenylephrine acts as a selective alpha-1 adrenergic receptor agonist, providing effective nasal decongestion by constricting dilated blood vessels in the nasal mucosa. Chlorpheniramine Maleate, a first-generation antihistamine, mitigates allergic symptoms such as sneezing, rhinorrhea, and itching by competitively inhibiting histamine H1 receptors. Dextromethorphan Hydrobromide serves as a centrally acting antitussive, suppressing the cough reflex by influencing the cough center in the medulla oblongata without causing significant sedation or respiratory depression. Ephedrex Syrup is indicated for symptomatic relief of upper respiratory tract conditions including common cold, allergic rhinitis, and cough associated with bronchitis. The combination provides comprehensive relief by addressing nasal congestion, allergic manifestations, and cough simultaneously. It is recommended to be used as directed by a healthcare professional, with caution advised in patients with hypertension, cardiovascular disorders, glaucoma, or hyperthyroidism due to the sympathomimetic effects of Phenylephrine. Common side effects may include dizziness, dry mouth, and mild gastrointestinal discomfort. Ephedrex Syrup should be avoided in pediatric patients under two years of age and during pregnancy unless specifically prescribed.